HomeCompareRADCQ vs GBDC

RADCQ vs GBDC: Dividend Comparison 2026

RADCQ yields 20000.00% · GBDC yields 11.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RADCQ wins by $52481917574412746752.00M in total portfolio value
10 years
RADCQ
RADCQ
● Live price
20000.00%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$52481917574412746752.00M
Annual income
$51,970,745,957,167,775,000,000,000.00
Full RADCQ calculator →
GBDC
GBDC
● Live price
11.85%
Share price
$12.66
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.78M
Annual income
$16,389,263.41
Full GBDC calculator →

Portfolio growth — RADCQ vs GBDC

📍 RADCQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRADCQGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RADCQ + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RADCQ pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RADCQ
Annual income on $10K today (after 15% tax)
$1,700,000.00/yr
After 10yr DRIP, annual income (after tax)
$44,175,134,063,592,610,000,000,000.00/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.11/yr
After 10yr DRIP, annual income (after tax)
$13,930,873.90/yr
At 15% tax rate, RADCQ beats the other by $44,175,134,063,592,610,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RADCQ + GBDC for your $10,000?

RADCQ: 50%GBDC: 50%
100% GBDC50/50100% RADCQ
Portfolio after 10yr
$26240958787206373376.00M
Annual income
$25,985,372,978,583,888,000,000,000.00/yr
Blended yield
99.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

RADCQ
Analyst Ratings
1
Buy
6
Hold
3
Sell
Consensus: Hold
Altman Z
0.9
Piotroski
3/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.6% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RADCQ buys
0
GBDC buys
0
No recent congressional trades found for RADCQ or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRADCQGBDC
Forward yield20000.00%11.85%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$52481917574412746752.00M$20.78M
Annual income after 10y$51,970,745,957,167,775,000,000,000.00$16,389,263.41
Total dividends collected$52448189483771600896.00M$20.36M
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusHoldBuy

Year-by-year: RADCQ vs GBDC ($10,000, DRIP)

YearRADCQ PortfolioRADCQ Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$2,010,700$2,000,000.00$12,490$1,790.28+$2.00MRADCQ
2$377,983,225$375,831,775.70$16,522$3,157.73+$377.97MRADCQ
3$66,433,479,469$66,029,037,418.28$23,578$5,898.68+$66433.46MRADCQ
4$10,916,985,471,987$10,845,901,648,955.73$37,115$11,886.75+$10916985.43MRADCQ
5$1,677,384,363,769,318$1,665,703,189,314,291.80$66,136$26,423.57+$1677384363.70MRADCQ
6$240,985,175,079,139,100$239,190,373,809,905,920.00$137,257$66,491.44+$240985175079.00MRADCQ
7$32,373,573,631,143,694,000$32,115,719,493,809,017,000.00$341,734$194,868.54+$32373573631143.36MRADCQ
8$4,066,766,648,320,630,000,000$4,032,126,924,535,306,000,000.00$1,050,788$685,133.02+$4066766648320629.00MRADCQ
9$477,730,483,406,513,300,000,000$473,379,043,092,810,300,000,000.00$4,099,314$2,974,971.01+$477730483406513344.00MRADCQ
10$52,481,917,574,412,750,000,000,000$51,970,745,957,167,775,000,000,000.00$20,775,530$16,389,263.41+$52481917574412746752.00MRADCQ

RADCQ vs GBDC: Complete Analysis 2026

RADCQStock

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and seasonal merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line. It also operates retail pharmacies and clinics; and offers healthcare services, including administering immunizations for COVID-19, the flu, shingles, and others; assists its customers with high blood pressure, cholesterol, and diabetes; provides guidance on combating obesity and tobacco addiction; and educates customers on managing medications and potential side effects. The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups. This segment serves health plans, commercial employers, labor groups, and state and local governments. In addition, it offers its products through online retail site. Rite Aid Corporation was founded in 1962 and is headquartered in Philadelphia, Pennsylvania. On October 15, 2023, Rite Aid Corporation, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of New Jersey.

Full RADCQ Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this RADCQ vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RADCQ vs SCHDRADCQ vs JEPIRADCQ vs ORADCQ vs KORADCQ vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.